abstract |
The present invention relates to the therapeutic use of stabilized oligoribonucleotides as immunomodulators for immunotherapeutic applications. In particular, the present invention provides RNA based oligoribonucleotides having increased nuclease and RNase stability and having immunomodulatory activity through TLR7 and / or TLR8. |